Serum leptin level in hypertensive middle-aged obese women

Endocrinologist

Volumn 15, Issue 4, 2005, Pages 219-221

  De Moraes, Camila ^a   Romero, Carla E M ^a   Farias Silva, Elisangela ^b   Zanesco, Angelina ^a,c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c NONE   (Brazil)

Author keywords

Blood pressure; Leptin; Obesity; Women

Indexed keywords

INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; OBESITY; SYMPATHETIC TONE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 23244447002     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000170963.12130.70     Document Type: Article

References (19)

1. Redon J. Hypertension in obesity. Nutr Metab Cardiovasc Dis. 2001; 11:344-353.
2. Ahima RS, Flier J. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11:327-332.
3. Sandoval DA, Davis SN. Leptin: metabolic control and regulation. J Diabetes Complications. 2003;17:108-113.
4. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S-15S.
5. Dunbar JC, Hu Y, Lu H. Intracerobroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes. 1997;46:2040-2043.
6. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:374-382.
7. Haynes WG, Morgan DA, Walsh SA, et al. Cardiovascular consequences of obesity: role of leptin. Clin Exp Pharmacol Physiol. 1998; 25:65-69.
8. Lembo G, Vecchione C, Fratta L, et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes. 2000;49:293-297.
9. Mallamaci F, Cuzzola F, Tripepi G, et al. Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens. 2000;8:914-920.
10. Suter PM, Locher R, Hasler E, et al. Is there a role of ob gene product leptin in essential hypertension? Am J Hypertens. 1998;11:1305-1311.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
12. Considine RV. Regulation of leptin production. Rev Endocr Metab Disord. 2001;2:357-363.
13. Jones PP, Snitker S, Skinner JS, et al. Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am J Physiol. 1996;270:E363-366.
14. Gordon T, Kannel WB, Castelli WP, et al. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med. 1981;14: 1128-1131.
15. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257:2176-2180.
16. Williams IL, Wheatcroft SB, Shah AM, et al. Obesity, arthrosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obesity Relat Metab Disord. 2002;26:754-764.
17. Saad MF, Kahn A, Sharma K, et al. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 1998;47:544-549.
18. Mueller WM, Gregoire FM, Stanhope KL, et al. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes. Endocrinology. 1998;138:551-558.
19. Wellhoener P, Fruehwald-Schultes B, Kem W, et al. Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab. 2000;85:1267-1271.